Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001161697-22-000411
Filing Date
2022-08-23
Accepted
2022-08-23 15:42:34
Documents
44
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A AMENDMENT NO. 1 TO QUARTERLY REPORT FOR 06-30-2022 form_10-q.htm   iXBRL 10-Q/A 633830
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CEO ex_31-1.htm EX-31 10237
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CFO ex_31-2.htm EX-31 10228
4 SECTION 1350 CERTIFICATION OF CEO ex_32-1.htm EX-32 5002
5 SECTION 1350 CERTIFICATION OF CFO ex_32-2.htm EX-32 4993
  Complete submission text file 0001161697-22-000411.txt   3047694

Data Files

Seq Description Document Type Size
6 INLINE XBRL SCHEMA FILE gstc-20220630.xsd EX-101.SCH 29978
7 INLINE XBRL CALCULATION FILE gstc-20220630_cal.xml EX-101.CAL 33781
8 INLINE XBRL DEFINITION FILE gstc-20220630_def.xml EX-101.DEF 115899
9 INLINE XBRL LABEL FILE gstc-20220630_lab.xml EX-101.LAB 238413
10 INLINE XBRL PRESENTATION FILE gstc-20220630_pre.xml EX-101.PRE 185355
38 EXTRACTED XBRL INSTANCE DOCUMENT form_10-q_htm.xml XML 312503
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 509-531-1671
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 000-55072 | Film No.: 221187256
SIC: 2834 Pharmaceutical Preparations